Clinical Trial Update: Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of dovramilast in people with erythema nodosum leprosum (leprosy type 2 reaction). The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Nodosum Leprosum
• Leprosy

Drugs mentioned

• Dovramilast (dovramilast)

Snippet

Sponsor: Medicines Development for Global Health | Conditions: Erythema Nodosum Leprosum | Phase 2 | Status: NOT_YET_RECRUITING